Skip to main content
Donate

Celebrating the First Angelman Syndrome Congress in Latin America: A Milestone for FAST Latam

We are thrilled to share the resounding success of the inaugural Angelman Syndrome Congress in Bogotá, Colombia, organized by FAST Latam. This historic event marks a significant step forward for the Angelman syndrome community in Latin America, where connections were made, knowledge shared, and hope reignited.

With over 180 attendees present in Bogotá and over 290 participants joining virtually from more than 30 countries, the Congress created a powerful platform for families, caregivers, researchers, and medical professionals to come together in advancing the understanding and treatment of Angelman Syndrome. The turnout, both in-person and online, speaks volumes about the determination and strength of the Latin American AS community.

It was a special honor for Allyson Berent (Chief Scientific Officer) Ellen Koekoeckx (Global Advisor), Amelia Beatty and Roy Azout (Board of Directors), to witness this momentous event firsthand. Their presence highlighted the global support for this cause, underscoring the incredible impact that FAST Latam has had in building a robust network in the region.

We are immensely proud of FAST Latam for their relentless dedication and hard work. The Congress not only amplified awareness but also brought vital resources to families who previously had limited access to AS-related information and support.

To everyone who attended, supported, and worked behind the scenes to make this Congress a reality—thank you. And a special thanks to Stephanie Azout, who is leading the amazing FAST Latam team and who made this first Congress a reality. Your contributions are shaping a brighter future for those living with Angelman syndrome in Latin America and beyond.

Together, we are stronger.

Watch the recap video!

Disclaimer

This website contains information for a broad audience and may include information on current and upcoming programs that are not yet approved or accessible The information provided is for general informational purposes only and is not intended as medical advice, diagnosis, or treatment. While FAST strives to provide accurate and up-to-date information, the content on this site may not always reflect the most current research or clinical guidelines. The inclusion of clinical trial information, treatments or specific healthcare providers does not imply endorsement, recommendation or guarantee of safety, efficacy, or availability. Reliance on any information provided by this website is solely at your own risk. FAST disclaims any liability for any errors or omissions in the information provided or for any decisions made based on this information. For personalized medical advice or specific health concerns including participation in any clinical trial, please consult a qualified healthcare professional.